Concepedia

Tatiana M. Kazdoba

TM

20

Publications

1.1K

Citations

16

H-Index

2003

Active since

Affiliations

Sage Therapeutics (United States)(Current)

Rutgers, The State University of New Jersey

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of California, Davis

United States Military Academy

Tatiana M. Kazdoba is an author at Sage Therapeutics (United States) specializing in medicine, neuroscience, and neuropharmacology.

Top concepts

Publications per year

2003–2023

20

Publications

20

Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator

Alison L. Althaus, Michael A. Ackley, Gabriel M. Belfort et al. · Neuropharmacology · 2020 · 120 citations · Full text

Reelin deficiency causes specific defects in the molecular composition of the synapses in the adult brain

Annamaria Ventruti, Tatiana M. Kazdoba, Sanyong Niu et al. · Neuroscience · 2011 · 95 citations

, , +11

Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders

Robert A. Hodgson, Paul J. Bédard, Geoffrey B. Varty et al. · Experimental Neurology · 2010 · 93 citations

, , +11

R-Baclofen Reverses Cognitive Deficits and Improves Social Interactions in Two Lines of 16p11.2 Deletion Mice

Laura J. Stoppel, Tatiana M. Kazdoba, Melanie D. Schaffler et al. · Neuropsychopharmacology · 2017 · 93 citations · Full text

Dab1 Is Required for Synaptic Plasticity and Associative Learning

Justin H. Trotter, Gum Hwa Lee, Tatiana M. Kazdoba et al. · Journal of Neuroscience · 2013 · 87 citations · Full text

, , +17

Rows per page

1–5 of 20